Volume 39 Issue 12
Dec.  2023
Turn off MathJax
Article Contents
Article Navigation >  Journal of Nanjing University of traditional Chinese Medicine  > 2023  >  39(12): 1179-1188
LI Wen-ting, ZHANG Qi, WU Mian-hua, LI Li, JIANG Ze-qun, ZHANG Yu, YANG Wei-hao, FEI Fan. Proteomics-Based Study on the Mechanism of Xiaoai Jiedu Recipe Regulating Nrf2/HMOX1 Pathway to Promote Ferroptosis in Hepatocellular Carcinoma Cells[J]. Journal of Nanjing University of traditional Chinese Medicine, 2023, 39(12): 1179-1188. doi: 10.14148/j.issn.1672-0482.2023.1179
Citation: LI Wen-ting, ZHANG Qi, WU Mian-hua, LI Li, JIANG Ze-qun, ZHANG Yu, YANG Wei-hao, FEI Fan. Proteomics-Based Study on the Mechanism of Xiaoai Jiedu Recipe Regulating Nrf2/HMOX1 Pathway to Promote Ferroptosis in Hepatocellular Carcinoma Cells[J]. Journal of Nanjing University of traditional Chinese Medicine, 2023, 39(12): 1179-1188. doi: 10.14148/j.issn.1672-0482.2023.1179
shu

Proteomics-Based Study on the Mechanism of Xiaoai Jiedu Recipe Regulating Nrf2/HMOX1 Pathway to Promote Ferroptosis in Hepatocellular Carcinoma Cells

doi: 10.14148/j.issn.1672-0482.2023.1179
  • 1.

    The First School of Clinical Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China

  • 2.

    Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjing 210023, China

  • 3.

    School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China

  • Received Date: 2023-06-30
    Available Online: 2023-12-20
    Abstract
  •   OBJECTIVE  To investigate the mechanism of Xiaoai Jiedu Recipe in promoting ferroptosis of tumor cells and inhibiting the growth of transplanted tumors in hepatocellular carcinoma mice by proteomics method.  METHODS  C57BL/6J mice were randomly divided into, model group, low- and high-dose groups of Xiaoai Jiedu Recipe, Xiaoai Jiedu Recipe combined with ferroptosis inhibitor group, ferroptosis inhibitor group and cisplatin group. The H22 mouse transplantation tumor model was constructed and the drug administration interventions were as follows: the low- and high-dose groups of Xiaoai Jiedu Recipe were given Xiaoai Jiedu Recipe by gavage at the doses of 10 and 20 g·kg-1·d-1; the ferroptosis inhibitor group was given Liproxstatin-1 by intraperitoneal injection at the dose of 10 mg·kg-1·d-1; the cisplatin group was given cisplatin by intraperitoneal injection at the dose of 10 mg·kg-1·d-1; the Xiaoai Jiedu Recipe combined with ferroptosis inhibitor group was given a gavage dose of 20 g·kg-1·d-1of Xiaoai Jiedu Recipe and an intraperitoneal injection of 10 mg·kg-1·d-1 of the ferroptosis inhibitor Liproxstatin-1; the model group was given an equal amount of saline by gavage. The drugs were administered for 11 d continuously. The tumors were stripped to calculate tumor inhibition rate. Pathological changes were observed by hematoxylin-eosin (HE). Mitochondrial structural changes were observed by transmission electron microscopy. Reactive oxygen species (ROS) levels were detected by flow cytometry. Serum was prepared and analysed by TMT peptide labelling combined with LC-MS/MS to find differential protein expression profiles, applying IPA software. Serum iron ions, glutathione (GSH) and malondialdehyde (MDA) levels were measured biochemically. Protein expression levels of nuclear factor E2-related factor 2 (Nrf2), heme oxygenase-1 (HMOX1), cystine/glutamate reverse transporter protein (SLC7A11) and glutathione peroxidase 4 (GPX4) were measured by protein Western blot.  RESULTS  The tumor growth was inhibited in the low- and high-dose groups and the cisplatin group, with inhibition rates of 36.12%, 51.63% and 57.43%, respectively, while the tumor growth was promoted in the ferroptosis inhibitor group, with an inhibition rate of -45.56%, and the tumor size was reduced in the Xiaoai Jiedu Recipe combined with ferroptosis inhibitor group compared with the ferroptosis inhibitor group, with an inhibition rate of 18.11%. HE staining showed that apoptotic cells and a large number of vacuoles accumulated in the tumor tissues of the high-dose group and the cisplatin group. Transmission electron microscopy showed that the mitochondrial atrophy and membrane density increased to a certain extent in the low and high-dose groups of Xiaoai Jiedu Recipe. Flow cytometry results showed that ROS levels were significantly increased after the intervention of Xiaoai Jiedu Recipe (P < 0.01). Proteomic tests showed that there were 129 differential proteins, including 62 down-regulated proteins and 67 up-regulated proteins, in the high-dose group of Xiaoai Jiedu Recipe compared with the model group, and these differential expressions were involved in lipid metabolism, et al. The results of biochemical tests showed that the intervention of Xiaoai Jiedu Recipe increased the serum iron and MDA levels, and decreased the GSH level in mice. Western blot results showed that the protein expression levels of Nrf2 and HMOX1 increased, and those of SLC7A11 and GPX4 decreased after the intervention of the high-dose group of Xiaoai Jiedu Recipe (P < 0.01).  CONCLUSION  Xiaoai Jiedu Recipe promotes ferroptosis in hepatocellular carcinoma cells by inducing the Nrf2/HMOX1 signaling pathway, regulating oxidative stress and elevating the level of lipid peroxidation, which may be one of its mechanisms of action in inhibiting the growth of transplanted tumors.

     

    • FullText(HTML)
  • loading
    • References(26)
  • [1]
    中华人民共和国国家卫生健康委员会. 原发性肝癌诊疗指南(2022年版)[J]. 肿瘤综合治疗电子杂志, 2022, 8(2): 16-53. https://www.cnki.com.cn/Article/CJFDTOTAL-XIBU202304002.htm

    National Health Commission of the People's Republic of China. Guidelines for the diagnosis and treatment of primary hepatic carcinoma(2022 edition)[J]. J Multidiscip Cancer Manag Electron Version, 2022, 8(2): 16-53. https://www.cnki.com.cn/Article/CJFDTOTAL-XIBU202304002.htm
    [2]
    SIA D, VILLANUEVA A, FRIEDMAN SL, et al. Liver cancer cell of origin, molecular class, and effects on patient prognosis[J]. Gastroenterology, 2017, 152(4): 745-761. doi: 10.1053/j.gastro.2016.11.048
    [3]
    徐菲, 曾杨丽, 李娟, 等. 中药复方防治肝癌作用机制研究进展[J]. 中国实验方剂学杂志, 2019, 25(24): 196-204. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX201924039.htm

    XU F, ZENG YL, LI J, et al. Mechanism of traditional Chinese medicine compound in preventing and treating hepatocellular carcinoma[J]. Chin J Exp Tradit Med Formulae, 2019, 25(24): 196-204. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX201924039.htm
    [4]
    曹毛毛, 陈万青. 中国恶性肿瘤流行情况及防控现状[J]. 中国肿瘤临床, 2019, 46(3): 145-149. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZL201903010.htm

    CAO MM, CHEN WQ. Epidemiology of cancer in China and the current status of prevention and control[J]. Chin J Clin Oncol, 2019, 46(3): 145-149. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZL201903010.htm
    [5]
    陈海彬, 周红光, 程海波, 等. 消癌解毒方对中晚期恶性肿瘤患者免疫功能的影响[J]. 南京医科大学学报(自然科学版), 2009, 29(9): 1257-1259. https://www.cnki.com.cn/Article/CJFDTOTAL-NJYK200909016.htm

    CHEN HB, ZHOU HG, CHENG HB, et al. Immune function of Xiaoaijiedufang on patients with advanced malignant tumor[J]. Acta Univ Med Nanjing Nat Sci, 2009, 29(9): 1257-1259. https://www.cnki.com.cn/Article/CJFDTOTAL-NJYK200909016.htm
    [6]
    周红光, 陈海彬, 吴勉华, 等. 消癌解毒方配合化疗治疗中晚期恶性肿瘤临床疗效观察[J]. 中华中医药杂志, 2010, 25(7): 1140-1143. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201007060.htm

    ZHOU HG, CHEN HB, WU MH, et al. Clinical observation of Xiao'ai Jiedu Prescription combined with chemotherapy on advanced cancer[J]. China J Tradit Chin Med Pharm, 2010, 25(7): 1140-1143. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201007060.htm
    [7]
    QIU WL, WANG ZQ, CHEN R, et al. Xiaoai Jiedu recipe suppresses hepatocellular carcinogenesis through the miR-200b-3p/Notch1 axis[J]. Cancer Manag Res, 2020, 12: 11121-11131.
    [8]
    WANG YC, XU CH, XU B, et al. Xiaoai Jiedu recipe inhibits proliferation and metastasis of non-small cell lung cancer cells by blocking the P38 mitogen-activated protein kinase (MAPK) pathway[J]. Med Sci Monit, 2019, 25: 7538-7546.
    [9]
    刘兵, 马英创. 消癌解毒方提取物对乳腺癌细胞增殖活力、细胞周期蛋白、PI3K/AKT通路的调节作用[J]. 中国处方药, 2021, 19(7): 7-9. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGCF202107007.htm

    LIU B, MA YC. Regulatory effects of Xiaoai Jiedu Decoction extracts on proliferation activity, cyclins and PI3K/AKT pathway of breast cancer cells[J]. J China Prescr Drug, 2021, 19(7): 7-9. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGCF202107007.htm
    [10]
    沈政洁, 黎思苑, 徐丽贤, 等. 消癌解毒方含药血清增强NK细胞杀伤结肠癌的作用及机制[J]. 中国实验方剂学杂志, 2022, 28(13): 85-91. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX202213011.htm

    SHEN ZJ, LI SY, XU LX, et al. Xiaoai Jiedu prescription-containing serum enhances lethal effect of NK cells on colon cancer cells[J]. Chin J Exp Tradit Med Formulae, 2022, 28(13): 85-91. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX202213011.htm
    [11]
    DIXON SJ, LEMBERG KM, LAMPRECHT MR, et al. Ferroptosis: An iron-dependent form of nonapoptotic cell death[J]. Cell, 2012, 149(5): 1060-1072.
    [12]
    李文婷, 吴勉华, 赵凤鸣, 等. 比较蛋白质组学分析揭示消癌解毒方含药血清作用人肝癌SMMC-7721细胞差异蛋白表达[J]. 中华中医药杂志, 2016, 31(5): 1828-1835. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201605065.htm

    LI WT, WU MH, ZHAO FM, et al. Effects of Xiao'ai Jiedu Formula drug-containing serum on expression of differential proteins in human hepatoma SMMC-7721 cells by comparative proteomic analysis[J]. China J Tradit Chin Med Pharm, 2016, 31(5): 1828-1835. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201605065.htm
    [13]
    TONELLI C, CHIO ⅡC, TUVESON DA. Transcriptional regulation by Nrf2[J]. Antioxid Redox Signal, 2018, 29(17): 1727-1745.
    [14]
    MA Q. Role of nrf2 in oxidative stress and toxicity[J]. Annu Rev Pharmacol Toxicol, 2013, 53: 401-426.
    [15]
    RYTER SW. Heme oxgenase-1, a cardinal modulator of regulated cell death and inflammation[J]. Cells, 2021, 10(3): 515.
    [16]
    SUTTNER DM, DENNERY PA. Reversal of HO-1 related cytoprotection with increased expression is due to reactive iron[J]. FASEB J, 1999, 13(13): 1800-1809.
    [17]
    GORRINI C, HARRIS IS, MAK TW. Modulation of oxidative stress as an anticancer strategy[J]. Nat Rev Drug Discov, 2013, 12(12): 931-947.
    [18]
    CHIANG SK, CHEN SE, CHANG LC. A dual role of heme oxygenase-1 in cancer cells[J]. Int J Mol Sci, 2018, 20(1): 39.
    [19]
    HASSANNIA B, WIERNICKI B, INGOLD I, et al. Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma[J]. J Clin Invest, 2018, 128(8): 3341-3355.
    [20]
    YANG WS, STOCKWELL BR. Ferrotosis: Death by Lipid Peroxidation[J]. Trends Cell Biol, 2016, 26(3): 165-176.
    [21]
    LIU JY, XIA XJ, HUANG P. xCT: A critical molecule that links cancer metabolism to redox signaling[J]. Mol Ther, 2020, 28(11): 2358-2366.
    [22]
    KOPPULA P, ZHUANG L, GAN BY. Cystine transporter SLC7A11/xCT in cancer: Ferroptosis, nutrient dependency, and cancer therapy[J]. Protein Cell, 2021, 12(8): 599-620.
    [23]
    STOCKWELL BR, FRIEDMANN ANGELI JP, BAYIR H, et al. Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease[J]. Cell, 2017, 171(2): 273-285.
    [24]
    YANG WS, SRIRAMARATNAM R, WELSCH ME, et al. Regulation of ferroptotic cancer cell death by GPX4[J]. Cell, 2014, 156(1/2): 317-331.
    [25]
    ALIM I, CAULFIELD JT, CHEN YX, et al. Selenium drives a transcriptional adaptive program to block ferroptosis and treat stroke[J]. Cell, 2019, 177(5): 1262-1279. e25.
    [26]
    SHARMA GN, GUPTA G, SHARMA P. A comprehensive review of free radicals, antioxidants, and their relationship with human ailments[J]. Crit Rev Eukaryot Gene Expr, 2018, 28(2): 139-154.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(8)  / Tables(2)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (258) PDF downloads(31) Cited by()
    Proportional views
    Related

    Copyright © Journal of Nanjing University of traditional Chinese Medicine

    Sponsored by：Nanjing University of traditional Chinese MedicineAddress：No.138 xianlin Avenue, Qixia District, Nanjing cityChina Pos：210023

    Tel：025-85811935Email：xb@njucm.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return